Antimicrobial Pharmacokinetics/dynamics Bedside ... - SWAB

More documents

Recommendations

Info

Volume of distribution (Vd) of ciprofloxacin400 mg bid IV in 32 critically ill patientsA.R.H. van Zanten. J Crit Care 2008
AUC 1-241ciprofloxacin 2 x 400 mg IV in 32critically illAUC/MIC > 100 for different MIC levelsAUC2001801601401201008060402001 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31patientCiprofloxacin pharmacokinetics in criticallyill patients: A prospective cohort study.J Crit Care 2008 Arthur R.H. van Zanten, et al
Page 1 and 2: Antimicrobial Pharmacokinetics/dyna
Page 3 and 4: Inappropriate therapy and VAP morta
Page 5 and 6: Antibiotic dosing strategies in ren
Page 7 and 8: SepsisIncreased CardiacOutputLeaky
Page 9 and 10: Continuous Renal Replacement Therap
Page 11 and 12: Basic principlesExtracorporeal clea
Page 13 and 14: Efficacy and PharmacodynamicsDrug l
Page 15 and 16: Use of ciprofloxacin in the critica
Page 17: Quinolones: AUC/MIC > 125AUC above
Page 21 and 22: Simulated fractional attainment of
Page 23 and 24: β-lactam static effects: streptoco
Page 25 and 26: More antibiotic specific: T > MIC f
Page 27 and 28: Randomised, prospective, open singl
Page 29 and 30: Systematic review on clinical benef
Page 31 and 32: Total costs of intravenous antibiot
Page 33 and 34: The jury is still out on continuous
Page 35 and 36: Pk during CVVH various antibiotics3
Page 37 and 38: Risk of underdosingHydrophylic anti
Page 39: Thank you!Arthur van Zantenzantena@

Antimicrobial Pharmacokinetics/dynamics Bedside ... - SWAB

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?